Clinical Trials – For the Patient

By participating in clinical trials conducted at Kardio-Med Silesia, we want to provide our patients access to innovative treatment.

Clinical trials are designed to test whether a new treatment is safe and effective. The results of ongoing clinical trials are new ways to prevent, diagnose or treat particular diseases. Clinical trials directly contribute to advances in medicine. Thanks to them, new medicines enter into widespread use.

Participation in a clinical trial is an opportunity to improve the health of people for whom previous treatments have proved ineffective or not very effective.

The most important thing in clinical trials is safety and the protection of patients’ rights, which is why all studies are conducted in accordance with current law, including the principles of Good Clinical Practice (GCP). GCP rules apply worldwide, including in Poland.

The decision to qualify a patient for treatment is made by the physician-investigator, who oversees the health and safety of the patient in the clinical research. When referring our patients to trials, we keep in mind, first and foremost, the benefits they can derive from them.

THE PATIENTS’ DECISION TO PARTICIPATE IN A CLINICAL TRIAL IS VOLUNTARY AND MUST BE MADE IN FULL KNOWLEDGE.

The patient has the right to refuse to participate in a clinical trial without any consequences. In the event of refusal to participate in the trial, the patient does not lose his/her rights to standard of care treatment.

THE PATIENTS’ PARTICIPATION IN THE CLINICAL TRIAL IS FREE OF CHARGE.

All incurred costs of treatment (the cost of study drugs, specialized tests and medical care) are borne by the clinical trial sponsor.

A PATIENT PARTICIPATING IN A CLINICAL TRIAL:

Anyone interested in participating in the study is welcome to contact our center for more information and to schedule an information appointment.

Contact:

Silesian Park of Medical Technology Kardio-Med Silesia
Marii Curie – Skłodowskiej Street 10C, 41-800 Zabrze, Poland

Clinical Research Coordinator: Dominika Pisulska

Phone: (+48 32) 70 50 305, faks: (+48 32) 70 50 300, e-mail: badaniakliniczne@kmptm.pl



    This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

    I consent to the processing of my personal data by Śląski Park Technologii Medycznych Kardio-Med Silesia Sp. z o.o., 10C M. Curie-Skłodowskiej St., 41-800 Zabrze, KRS:0000396540, NIP:6482761515, Regon:242742607, as Data Controler in order to receive a response. I can withdraw my consent by submitting a statement to: iod@kmptm.pl. The Data Controler has notified me that this consent does not affect the legality of the processing carried out on the basis of consent before its withdrawal.

    The information clause on the details of the processing is available here.

    Supporting partners:

    Partners: